Chiara Novelli: Are We Validating Laboratory Algorithms as Rigorously as We Validate Laboratory Tests?
Chiara Novelli, Senior Biologist at Legnano Civil Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in International Journal of Laboratory Hematology, adding:
“Recently, our work on the implementation and validation of an automated Lupus Anticoagulant interpretation algorithm has been published in the ‘International Journal of Laboratory Hematology’.
The project was developed across a four-hospital laboratory network and focused not only on LA testing itself, but also on a broader question that many laboratories are increasingly facing:
How should we properly validate rule-based algorithms implemented in middleware and LIS environments?
As laboratory diagnostics become more complex, middleware systems are evolving from simple technical tools into true decision-support platforms.
However, while analytical validation is highly standardized, validation strategies for middleware algorithms often remain heterogeneous and poorly defined.
In our experience, key elements for a robust validation framework include:
- Hierarchical and traceable rule design
- Retrospective and prospective validation
- Discrepant-case analysis
- Management of analytical interferences and exceptions
- Continuous post-implementation monitoring
- Preservation of expert oversight for complex cases
Beyond standardization and turnaround time optimization, one of the most interesting aspects was observing how structured workflows can reduce inter-operator variability and support less experienced professionals without replacing clinical expertise.
I believe this topic goes far beyond coagulation testing and may become increasingly relevant for laboratory governance, accreditation processes, and AI-assisted diagnostics.
I would be very interested to hear how other laboratories are approaching these challenges:
- How do you validate middleware algorithms in your institution?
- Do you use retrospective datasets, prospective parallel testing, or both?
- How do you manage traceability and version control of rules?
- Where do you draw the line between autoverification and mandatory expert review?
- Are existing CLSI/ISTH recommendations sufficient for modern middleware ecosystems?”
Title: Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing
Authors: Chiara Novelli, Arianna Gatti, Flora Ierna, Elena Riccardi, Irene Cuppari

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
-
Jul 16, 2026, 18:40Sara Buonomo: Predicting Relapse in Immune-Mediated TTP at ISTH 2026